Deutsches krebsforschungszentrum:1164217 [17-051155]

Ended Purchase Order Awarded Last action

Contract number
HHSN261201700674P
Awardee
Awarding agency
Obligated
$18,876

Award facts

Contract value 100% obligated
$18,876.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541711 Research and Development in Biotechnology
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Germany

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute awarded a purchase order to Deutsches Krebsforschungszentrum on September 18, 2017, with a ceiling value of $18,876.00 under firm fixed-price terms. Performance is located in Germany, with an ultimate completion date of September 24, 2018. The procurement was issued under open competition with no set-aside designation.

Quick answers

Who was awarded contract HHSN261201700674P?

HHSN261201700674P was awarded to Deutsches Krebsforschungszentrum by National Cancer Institute (National Institutes of Health) on September 18, 2017.

How much is contract HHSN261201700674P worth?

The government has obligated $18,876 on HHSN261201700674P.

Was contract HHSN261201700674P competed?

The extent of competition for HHSN261201700674P was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award